Cyclacel Pharmaceuticals Announces Multiple Clinical Abstracts Selected for Presentation at the ASH 2019 Annual Meeting

NEXT STORY
Forty Seven, Inc. to Present New Clinical and Preclinical Data on Magrolimab and FSI-174 at 61st ASH Annual Meeting
PREV STORY
Predictive Oncology Featured in Publication Discussing the Impact of Artificial Intelligence on Cancer Treatment
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Bavarian Nordic Announces Initiation of Phase 2 Trial of BN-Brachyury for the Treatment of Chordoma

First dose has been administered in the multiple-center study BN-Brachyury for the treatment of chordoma ...

author_avatar
NASDAQ Market News

Chembio Diagnostics to Report First Quarter 2019 Financial Results on May 1, 2019

author_avatar
NASDAQ Market News

Junshi Biosciences Announces Approval of Supplemental New Drug Application by NMPA for Toripalimab in Combination with Cisplatin and Gemcitabine as First-Line Treatment for Patients with Locally Recurrent or Metastatic Nasopharyngeal Carcinoma

author_avatar
NASDAQ Market News